Elastic modulus of FRP confined CGC. by Qingwen Li (1510687)

“…This study is of great significance for selecting the appropriate type of FRP confinement for concrete under different coal gangue replacement rates.…”

GFRP confined concrete specimens. by Qingwen Li (1510687)

“…This study is of great significance for selecting the appropriate type of FRP confinement for concrete under different coal gangue replacement rates.…”

13 Compressive strength of FRP confined CGC. by Qingwen Li (1510687)

“…This study is of great significance for selecting the appropriate type of FRP confinement for concrete under different coal gangue replacement rates.…”

Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism i... by Caina Li (4126462)

Subjects:

Vasopressor titration regimen in the balanced multimodal group. by Žiga Kalamar (22145810)

Subjects:

The schedule of enrollment, interventions and assessments. by Žiga Kalamar (22145810)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

PCA-DC cycle improvement process. by Jun Zhao (59250)

“…The optimization of anisotropic nodes significantly enhances the seismic performance of shear walls. …”

The results of linear mixed model. by Soheila Qanbari (20455173)

Subjects:

The flow of the participants from enrollment to analysis. by Soheila Qanbari (20455173)

Subjects:

Correlation between treatment-induced changes in lumbar motor control and N150 amplitude. by Soheila Qanbari (20455173)

Subjects:

Sensory-evoked potentials of N80 and N150. by Soheila Qanbari (20455173)

Subjects:

The mean and standard deviation of outcome measures. by Soheila Qanbari (20455173)

Subjects:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

Subjects: